SCHEMBL9047883

SCHEMBL9047883

CSc1ccc(-c2c(Cl)ncnc2NS(=O)(=O)c2ccc(C(C)C)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 4/20 0.45
EDNRB P24530 3/20 0.45
ALDH1A1 P00352 8/20 0.43
MAPT P10636 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 2/20 0.43
PKM P14618 1/20 0.43
KIT P10721 1/20 0.41
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
TSHR P16473 1/20 0.40
ALOX12 P18054 1/20 0.40
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9045520 0.92 EDNRA (0.51) EDNRAEDNRBALDH1A1MAPTSMN1; SMN2
SCHEMBL9046378 0.89 EDNRA (0.57) EDNRAEDNRBALDH1A1MAPTKIT
SCHEMBL9046700 0.87 EDNRA (0.49) EDNRAEDNRBALDH1A1MAPTKIT
SCHEMBL9043808 0.86 EDNRB (0.47) EDNRAEDNRBALDH1A1MAPTSMN1; SMN2
SCHEMBL9046082 0.86 ALDH1A1 (0.56) EDNRAEDNRBALDH1A1MAPTLMNA
SCHEMBL9494268 0.85 EDNRA (0.56) EDNRAEDNRBKITKMT2AMEN1
SCHEMBL9047430 0.84 EDNRA (0.47) EDNRAEDNRBALDH1A1LMNAKIT
SCHEMBL9053125 0.84 EDNRA (0.47) EDNRAEDNRBMAPTSMN1; SMN2LMNA
SCHEMBL9046552 0.83 EDNRA (0.57) EDNRAEDNRBKITMMP2MMP9
SCHEMBL9047331 0.83 EDNRA (0.68) EDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 EP disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 US disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 EP disclosed